DCOY Decoy Therapeutics Inc.
Company Analysis
Latest News
🟢 Decoy Therapeutics is trading 5.67% up today in pre-market
Decoy Therapeutics is trading 5.67% up now at $4.29, based on the provided pre-market quote; no clear August 7, 2026 company-specific catalyst was...
🔴 Decoy Therapeutics is trading 6.7% down today on profit-taking after recent gains
Decoy Therapeutics is trading 6.7% down at $4.08 as the stock gives back a portion of its sharp rebound from late-July lows. • There are no fresh...
🔴 Decoy Therapeutics is trading 8.2% down today with no clear catalyst
Decoy Therapeutics is trading 8.2% down at $4.01 today, extending yesterday’s consolidation after a sharp rebound from late-July lows. • There is currently no...
🔴 Decoy Therapeutics is trading 5.5% down today as shares consolidate after a multi-day rebound
Decoy Therapeutics is trading 5.5% down at $4.10 as shares consolidate following a sharp multi-day rebound from its July 27 plunge. • The move comes despite a...
🟢 Decoy Therapeutics is trading 7.79% up today in sentiment-driven rebound
Decoy Therapeutics is trading at $4.43 (+7.79%) in active morning trading, moving higher despite a lack of fresh company-specific news or fundamental...
🟢 Decoy Therapeutics is trading 5.3% up today with no clear catalyst
Decoy Therapeutics is trading at $4.33 (5.3%) up today, rebounding modestly from a sharp pullback on July 27 despite a lack of fundamental news. • The price...
🔴 Decoy Therapeutics is trading 8.6% down today after a sharp overnight selloff
Decoy Therapeutics is trading at $3.76 (-8.59%) in pre-market after a sharp overnight selloff with no clear catalyst identified. • No company-specific news,...
🟢 Decoy Therapeutics is trading 9% up today as Ebola Zaire data-driven rebound continues
Decoy Therapeutics is trading at $4.27 (9% up) in after-hours trading as the stock extends a rebound triggered by positive July 28 lab results for its Ebola...
🟢 Decoy Therapeutics is trading 10.2% up today after continued rebound from Ebola Zaire platform success
Decoy Therapeutics is trading at $4.44 (+10.17%) as it extends a rebound triggered by July 28 lab results for its Ebola Zaire platform. • The move appears to...
🟢 Decoy Therapeutics is trading 5.7% up today on an extended rebound from its Ebola Zaire platform success
Decoy Therapeutics is trading at $4.26 (+5.71%) in after-hours trading, extending a rebound tied to the success of its Ebola Zaire platform. • The move...
🟢 Decoy Therapeutics is trading 6.2% up today on Ebola Zaire platform success
Decoy Therapeutics is trading 6.2% up today at $4.29 as the stock extends its rebound following positive lab results for its antiviral platform against Ebola...
🔴 Decoy Therapeutics is trading 10.9% down today, giving back gains from its recent two-day rebound
Decoy Therapeutics is trading 10.9% down at $3.60, giving back part of its sharp two-day rebound following a period of high volatility. • The move follows a...
Decoy Therapeutics Proves Its Antiviral Platform Works Beyond COVID — But Can a $3 Million Company Capitalize on That Promise?
Shares of Decoy Therapeutics surged +10% to $4.12 Monday after the micro-cap biotech announced that a drug candidate originally built to fight coronaviruses...
🟢 Decoy Therapeutics is trading 10% up today after Ebola data validates D-MAV platform
Decoy Therapeutics is trading at $4.12 (+10.03%) after announcing that its D-MAV candidate showed in vitro activity against the wild-type Ebola Zaire virus. •...
🟢 Decoy Therapeutics is trading 6.4% up today as Ebola data validates D-MAV platform
Decoy Therapeutics is trading at $3.98 (up 6.4%) after announcing that a D-MAV candidate demonstrated in vitro activity against the wild-type Ebola Zaire...
Decoy Therapeutics Validates Platform, Proving In Vitro Activity Against Ebola Virus
Decoy Therapeutics Inc. reported on July 27, 2026, that a D-MAV candidate demonstrated in vitro activity against the wild-type Ebola Zaire virus. This finding...
🔴 Decoy Therapeutics is trading 6.4% down today, extending a multi-day slide with no clear catalyst
Decoy Therapeutics is trading 6.4% down at $3.50 in pre-market, extending a sharp multi-day slide that accelerated on July 27, 2026, despite a lack of...
🔴 Decoy Therapeutics is trading 20% down today, extending a multi-day slide with no clear catalyst
Decoy Therapeutics is trading at $4.03 (down 20%), extending a multi-day slide from last week with no fresh, company-specific news identified as a clear...
🔴 Decoy Therapeutics is trading 13.69% down today with no clear company-specific catalyst
Decoy Therapeutics is trading at $4.35 (-13.69%) in pre-market sessions as the stock extends a multi-day slide despite a lack of fresh fundamental news. • No...
🔴 Decoy Therapeutics is trading 5.8% down today, extending a multi-day slide with no clear catalyst
Decoy Therapeutics is trading 5.8% down at $4.75 in after-hours trading, extending a sharp multi-day slide from mid-July highs near $6. • There are no fresh...